Product Profile

Diphenhydramine, Ammonium Chloride, Sodium Citrate, and Menthol Oral Syrup represents the absolute pinnacle of multi-symptom, expectorant-based cough formulations. As a dominant WHO-GMP certified pharmaceutical manufacturer in Baddi, Saar Biotech leverages specialized aqueous-alcoholic compounding techniques to perfectly harmonize these four distinct therapeutic agents. This ensures complete molecular solubility, rapid onset of action, and deep, soothing relief for patients suffering from acute productive coughs and upper respiratory tract infections.

Manufacturing Advantage

Why Saar Biotech for Diphenhydramine + Ammonium Chloride + Sodium Citrate + Menthol Syrup?

Since {{ site.Params.founded }}, Saar Biotech has been a distinguished WHO-GMP certified leader in pharmaceutical manufacturing. We utilize advanced micronization and pH-stabilization protocols to deliver unmatched bioavailability for this Diphenhydramine + Ammonium Chloride + Sodium Citrate + Menthol Syrup formulation.

DCGI Approved

Comprehensive documentation and CDSCO support for rapid market entry in India.

Fast Turnaround

30-45 days lead time for new batches with state-of-the-art logistics.

Pan-India Supply & Contract Manufacturing

Batch Lead Time 30-45 Days (Domestic)
B2B Services Contract & Third-Party
Compliance DCGI & Schedule M Standards
Medical Intelligence

Clinical Q&A for Diphenhydramine + Ammonium Chloride + Sodium Citrate + Menthol Syrup

Technical data on bioavailability, pediatric dosing protocols, and therapeutic efficacy for healthcare professionals.

What are the clinical indications for Diphenhydramine + Ammonium Chloride + Sodium Citrate + Menthol Syrup?

This combination of diphenhydramine, sodium citrate and ammonium chloride is an antitussive and expectorant cough mixture. Antitussives are used to suppress or relieve/soothe coughing, while expectorants stimulate the respiratory tract to increase the production of bronchial secretions. This then thins mucus, facilitating the expulsion of phlegm or mucus from the respiratory tract. It is indicated for colds, hayfever, sneezing, coughing, itchy watery red eyes, and runny or blocked nose.

How does this four-component combination work?

Diphenhydramine is an antihistamine that relieves congestion and post-nasal drips. Ammonium Chloride is the expectorant which thins mucus. Sodium citrate is a mucolytic, an agent which breaks down mucus, so that coughing up phlegm is easier. Menthol is an expectorant with soothing properties. The rationale of combination is that Diphenhydramine relieves congestion and post-nasal drips, while ammonium chloride thins mucus, sodium citrate breaks down mucus, and Menthol helps clear.

What is the standard dosing protocol?

The standard adult dose is 5 to 10 ml taken three to four times daily, or as directed by a physician. The syrup should be shaken well before each use. A calibrated measuring cup should be used for accurate dosing. This medication is not intended for use in children under the age of 6 years.

What are the key drug interactions and precautions?

Alcohol, drugs for anxiety and sleeping tablets if co-administered along with the medication lead to enhanced sedation. Monoamine oxidase inhibitors and tricyclic antidepressants increase the occurrence of Diphenhydramine relating side-effects. Consult your doctor before using this drug if you have asthma, liver or kidney disease, glaucoma, epilepsy, a heart rhythm disturbance, an enlarged prostate, difficulty urinating, or if you have been diagnosed with myasthenia gravis.

What are the common side effects and pharmacokinetics?

Common side effects include dry mouth, dizziness, headache, nausea/vomiting, and gastrointestinal discomfort. Diphenhydramine is quickly absorbed with maximum activity occurring in approximately one hour. Protein binding is 98 to 99%, with hepatic and renal metabolism. The half-life is 1-4 hours.
Manufacturing Support

B2B Manufacturing Guide for Diphenhydramine + Ammonium Chloride + Sodium Citrate + Menthol Syrup

Detailed insights on MOQs, lead times, and regulatory support for contractmanufacturing partners.

What pack sizes and packaging options are available for this syrup?
Saar Biotech manufactures this cough syrup in 100 ml bottle formats. Packaging options include: sticker label, metallic label, silver leafing, drip-off brand embossed carton, UV finish carton, measuring cap, printed cap, company-logo printed PP cap, with-carton or without-carton supply. Our facility also provides bespoke packaging configurations and flexible pack volumes to align with your unique contract manufacturing needs.
What is the MOQ for this syrup?
Standard contract MOQs range from 5,000 to 10,000 units per pack size. This cough syrup has seasonal demand peaks during monsoon and winter, and our automated filling lines in Baddi support both brand-entry volumes and large commercial runs.
What analytical tests are performed on every batch?
Every batch undergoes HPLC Assay confirming all four actives against IP specifications. pH and viscosity testing confirms syrup stability. Microbial Limit Testing (MLT) meets IP specifications. A Certificate of Analysis (COA) is issued with every B2B consignment.
What is the turnaround time for a new order?
For fresh orders, the production timeline spans about 30 to 45 business days once designs are locked. Consistent repeat commercial orders are swiftly handled within a 20 to 25 working day window.
Do you offer private labelling and packaging design?
Yes, our in-house design team provides end-to-end support for private label packaging, including mono-cartons, labels, and promotional materials compliant with regulatory guidelines.
Call Us
WhatsApp
Email